Last updated on January 2014

Study in overweight and obese subjects with CV disease and/or multiple CV risk factors


Brief description of study

Study in overweight and obese subjects with CV disease and/or multiple CV risk factors

Detailed Study Description

A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors

Clinical Study Identifier: TX137663

Find a site near you

Start Over

Cardiology Research Associates

305 Memorial Medical Parkway Suite 301 Daytona Beach, FL USA
2.92miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.